New antibody-drug conjugate shows promising activity in salivary gland tumors

[News]

The antibody-drug conjugate ado-trastuzumab emtansine (T-DM1) has promising activity in HER2 amplified salivary gland tumors, according to data published in the Annals of Oncology.

More... (https://www.news-medical.net/news/20200107/New-antibody-drug-conjugate-shows-promising-activity-in-salivary-gland-tumors.aspx)